Beetroot supplemented diet exhibit anti-amnesic effect via modulation of cholinesterases, purinergic enzymes, monoamine oxidase and attenuation of redox imbalance in the brain of scopolamine treated male rats

References

• Najm R, Jones EA, Huang Y. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease. Mol Neurodegener. 2019;14(1):24.
   PubMedGoogle Scholar
• Zhang X, Fu Z, Meng L, He M, Zhang Z. The Early Events that Initiate beta-amyloid aggregation in Alzheimer's disease. Front Aging Neurosci. 2018;10:359.
   PubMed Web of Science ®Google Scholar
• Uttara B, Singh AV, Zamboni P, Mahajan RT. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol. 2009;7(1):65–74. Epub 2009/09/02.
   PubMed Web of Science ®Google Scholar
• Grossberg GT. Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying on. Curr Ther Res Clin Exp. 2003;64(4):216–35.
   PubMed Web of Science ®Google Scholar
• Ciobica A, Bild W, Hritcu L, Haulica I. Brain renin-angiotensin system in cognitive function: pre-clinical findings and implications for prevention and treatment of dementia. Acta Neurol Belg. 2009;109(3):171–80.
   PubMed Web of Science ®Google Scholar
• Riederer P. Monoamine oxidase-B inhibition in Alzheimer's disease. NeuroToxicology. 2004;25(1-2):271–7.
   PubMed Web of Science ®Google Scholar
• Gutierres JM, Carvalho FB, Schetinger MR, Rodrigues MV, Schmatz R, Pimentel VC, et al. Protective effects of anthocyanins on the ectonucleotidase activity in the impairment of memory induced by scopolamine in adult rats. Life Sci. 2012;91(23-24):1221–8.
   PubMed Web of Science ®Google Scholar
• Verheijen J, Sleegers K. Understanding Alzheimer disease at the interface between Genetics and Transcriptomics. Trends Genet. 2018;34(6):434–47.
   PubMed Web of Science ®Google Scholar
• Zaki HF, Abd-El-Fattah MA, Attia AS. Naringenin protects against scopolamine-induced dementia in rats. Bulletin of Faculty of Pharmacy, Cairo University. 2014;52:15–25.
   Google Scholar
• Zemek F, Drtinova L, Nepovimova E, Sepsova V, Korabecny J, Klimes J, Kuca K. Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine. Expert Opin Drug Saf. 2014;13(6):759–74.
   PubMed Web of Science ®Google Scholar
• Birks J, Harvey RJ. Donepezil for dementia Due to Alzheimer's disease. Cochrane Database Syst Rev. 2006;25:CD001190.
   Google Scholar
• Vulić JJ, Ćebović TN, Čanadanović-Brunet JM, Ćetković GS, Čanadanović VM, Djilas SM, Šaponjac VTT. In vivo and in vitro antioxidant effects of beetroot pomace extracts. J Funct Foods. 2014;6:168–75.
   Web of Science ®Google Scholar
• Clifford T, Howatson G, West DJ, Stevenson EJ. The potential benefits of red beetroot supplementation in health and disease. Nutrients. 2015;7(4):2801–22.
   PubMed Web of Science ®Google Scholar
• Kujala TS, Vienola MS, Klika KD, Loponen JM, Pihlaja K. Betalain and phenolic compositions of four beetroot (Beta vulgaris) cultivars. Eur Food Res Technol. 2002;214:505–10.
   Web of Science ®Google Scholar
• Ninfali P, Angelino D. Nutritional and functional potential of Beta vulgaris cicla and rubra. Fitoterapia. 2013;89:188–99.
   PubMed Web of Science ®Google Scholar
• Bond V, Curry BH, Adams RG, Asadi MS, Millis RM, Haddad GE. Effects of dietary Nitrates on Systemic and cerebrovascular Hemodynamics. Cardiol Res Pract. 2013;2013:1–9.
   Google Scholar
• Gilchrist M, Winyard PG, Fulford J, Anning C, Shore AC, Benjamin N. Dietary nitrate supplementation improves reaction time in type 2 diabetes: development and application of a novel nitrate-depleted beetroot juice placebo. Nitric Oxide. 2014;40:67–74.
   PubMed Web of Science ®Google Scholar
• Public Health Service (PHS). Public Health Service Policy on Humane Care and Use of Laboratory Animals, (PL 99–158. Health Research Extension Act, 1985). Washington, DC: US Department of Health and Human Services; 2015.
   Google Scholar
• Oboh G, Oyeleye SI, Akintemi OA, Olasehinde TA. Moringa oleifera supplemented diet modulates nootropic-related biomolecules in the brain of STZ-induced diabetic rats treated with acarbose. Metab Brain Dis. 2018;33(2):457–66.
   PubMed Web of Science ®Google Scholar
• Sadek B, Khan N, Darras FH, Pockes S, Decker M. The dual-acting AChE inhibitor and H3 receptor antagonist UW-MD-72 reverses amnesia induced by scopolamine or dizocilpine in passive avoidance paradigm in rats. Physiol Behav. 2016;165:383–91.
   PubMed Web of Science ®Google Scholar
• Akinyemi AJ, Oboh G, Oyeleye SI, Ogunsuyi O. Anti-amnestic effect of Curcumin in Combination with donepezil, an Anticholinesterase Drug: Involvement of cholinergic system. Neurotox Res. 2017;31(4):560–9.
   PubMed Web of Science ®Google Scholar
• Wall PM, Messier C. Infralimbic kappa opioid and muscarinic M1 receptor interactions in the concurrent modulation of anxiety and memory. Psychopharmacology (Berl. 2002;160(3):233–44.
   PubMed Web of Science ®Google Scholar
• Adeniyi PA, Ishola AO, Laoye BJ, Olatunji BP, Bankole OO, Shallie PD, Ogundele OM. Neural and behavioural changes in male periadolescent mice after prolonged nicotine-MDMA treatment. Metab Brain Dis. 2016;31(1):93–107.
   PubMed Web of Science ®Google Scholar
• Khan MB, Khan MM, Khan A, Ahmed ME, Ishrat T, Tabassum R, et al. Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model. Neurochem Int. 2012;61(7):1081–93.
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol. 1961;7:88–95.
   PubMed Web of Science ®Google Scholar
• Schetinger MR, Morsch VM, Bonan CD, Wyse AT. NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. Biofactors. 2007;31(2):77–98.
   PubMed Web of Science ®Google Scholar
• Chan K-M, Delfert D, Junger KD. A Direct Calorimetric assay for Ca2+-Stimulated ATPase activity. Anal Biochem. 1986;157:375–380
   PubMed Web of Science ®Google Scholar
• Heymann D, Reddington M, Kreutzberg GW. Subcellular localization of 5'-nucleotidase in rat brain. J Neurochem. 1984;43(4):971–8.
   PubMed Web of Science ®Google Scholar
• Giusti G, Gakis C. Temperature conversion factors, activation energy, relative substrate specificity and optimum pH of adenosine deaminase from human serum and tissues. Enzyme. 1971;12(4):417–25.
   PubMedGoogle Scholar
• Green AL, Haughton TM. A colorimetric method for the estimation of monoamine oxidase. Biochem J. 1961;78:172–5.
   PubMed Web of Science ®Google Scholar
• Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin- converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20(7):1637–48.
   PubMed Web of Science ®Google Scholar
• Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–6.
   PubMed Web of Science ®Google Scholar
• Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–7.
   PubMed Web of Science ®Google Scholar
• Kalinski JJ, Waterworth SC, Noundou XS, Jiwaji M, Parker-Nance S, Krause RWM. Molecular Networking Reveals Two Distinct Chemotypes in Pyrroloiminoquinone-Producing Tsitsikamma favus Sponges. Mar Drugs. 2019;17(1):12–16
   Web of Science ®Google Scholar
• Olasehinde TA, Olaniran AO, Okoh AI. Phenolic composition, antioxidant activity, anticholinesterase potential and modulatory effects of aqueous extracts of some seaweeds on beta-amyloid aggregation and disaggregation. Pharm Biol. 2019;57(1):460–9.
   PubMed Web of Science ®Google Scholar
• Zebisch M, Baqi Y, Schafer P, Muller CE, Strater N. Crystal structure of NTPDase2 in complex with the sulfoanthraquinone inhibitor PSB-071. J Struct Biol. 2014;185(3):336–41.
   PubMed Web of Science ®Google Scholar
• Binda C, Newton-Vinson P, Hubalek F, Edmondson DE, Mattevi A. Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol. 2002;9(1):22–6.
   PubMedGoogle Scholar
• Kinoshita T, Tada T, Nakanishi I. Conformational change of adenosine deaminase during ligand- exchange in a crystal. Biochem Biophys Res Commun. 2008;373(1):53–7.
   PubMed Web of Science ®Google Scholar
• Natesh R, Schwager SL, Sturrock ED, Acharya KR. Crystal structure of the human angiotensin- converting enzyme-lisinopril complex. Nature. 2003;421(6922):551–4.
   PubMed Web of Science ®Google Scholar
• Sanner MF. Python: a programming language for software integration and development. J Mol Graph Model. 1999;17(1):57–61.
   PubMed Web of Science ®Google Scholar
• Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, … Fox DJ. Gaussian 09, revision D. 01. In: Gaussian, Inc., Wallingford CT2009.
   Google Scholar
• Yang B, Hao F, Li J, Chen D, Liu R. Binding of chrysoidine to catalase: spectroscopy, isothermal titration calorimetry and molecular docking studies. J Photochem Photobiol B. 2013;128:35–42.
   PubMed Web of Science ®Google Scholar
• Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ. Autodock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem. 2009;30(16):2785–91.
   PubMed Web of Science ®Google Scholar
• Xie A, Gao J, Xu L, Meng D. Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease. Biomed Res Int. 2014;2014:648740.
   PubMed Web of Science ®Google Scholar
• Ferreira-Vieira TH, Guimaraes IM, Silva FR, Ribeiro FM. Alzheimer's disease: Targeting the cholinergic system. Curr Neuropharmacol. 2016;14(1):101–15.
   PubMed Web of Science ®Google Scholar
• Haam J, Yakel JL. Cholinergic modulation of the hippocampal region and memory function. J Neurochem. 2017;142(Suppl 2):111–21.
   PubMed Web of Science ®Google Scholar
• Sohn E, Lim HS, Kim YJ, Kim BY, Jeong SJ. Annona atemoya leaf Extract Improves scopolamine-induced memory impairment by preventing hippocampal cholinergic dysfunction and neuronal Cell Death. Int J Mol Sci. 2019;20(14):2–16
   Web of Science ®Google Scholar
• Greig NH, Utsuki T, Yu Q, Zhu X, Holloway HW, Perry T, et al. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin. 2001;17(3):159–65.
   PubMed Web of Science ®Google Scholar
• Grkovic I, Drakulic D, Martinovic J, Mitrovic N. Role of Ectonucleotidases in Synapse formation during brain development: Physiological and pathological Implications. Curr Neuropharmacol. 2019;17(1):84–98.
   PubMed Web of Science ®Google Scholar
• Yamazaki Y, Kaneko K, Fujii S, Kato H, Ito K. Long-term potentiation and long-term depression induced by local application of ATP to hippocampal CA1 neurons of the Guinea pig. Hippocampus. 2003;13(1):81–92.
   PubMed Web of Science ®Google Scholar
• Hauptmann S, Scherping I, Drose S, Brandt U, Schulz KL, Jendrach M, et al. Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging. 2009;30(10):1574–86.
   PubMed Web of Science ®Google Scholar
• Latini S, Pedata F. Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem. 2001;79(3):463–84.
   PubMed Web of Science ®Google Scholar
• Rahman A. The role of adenosine in Alzheimer’s disease. Curr Neuropharmacol. 2009;7:207–2016.
   PubMed Web of Science ®Google Scholar
• de Mendonca A, Ribeiro JA. Adenosine and neuronal plasticity. Life Sci. 1997;60(4-5):245–51.
   PubMed Web of Science ®Google Scholar
• de Mendonca A, Costenla AR, Ribeiro JA. Persistence of the neuromodulatory effects of adenosine on synaptic transmission after long-term potentiation and long-term depression. Brain Res. 2002;932(1-2):56–60.
   PubMed Web of Science ®Google Scholar
• Lee ST, Venton BJ. Regional Variations of spontaneous, Transient adenosine Release in brain Slices. ACS Chem Neurosci. 2018;9(3):505–13.
   PubMed Web of Science ®Google Scholar
• Arosio B, Casati M, Gussago C, Ferri E, Abbate C, Scortichini V, et al. Adenosine type A2A receptor in Peripheral Cell from patients with Alzheimer's disease, Vascular dementia, and Idiopathic normal Pressure Hydrocephalus: A New/Old potential target. J Alzheimers Dis. 2016;54(2):417–25.
   PubMed Web of Science ®Google Scholar
• Borroni E, Bohrmann B, Grueninger F, Prinssen E, Nave S, Loetscher H, et al. Sembragiline: A Novel, Selective monoamine oxidase type B inhibitor for the treatment of Alzheimer's disease. J Pharmacol Exp Ther. 2017;362(3):413–23.
   PubMed Web of Science ®Google Scholar
• Bortolato M, Chen K, Shih JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv Drug Deliv Rev. 2008;60(13-14):1527–33.
   PubMed Web of Science ®Google Scholar
• Thomas T. Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease. Neurobiol Aging. 2000;21:343–8.
   PubMed Web of Science ®Google Scholar
• Oyebode OA, Erukainure OL, Ibeji CU, Koorbanally NA, Islam MS. Phytochemical constituents, antioxidant and antidiabetic activities of different extracts of the leaves, stem and root barks of Alstonia boonei: an in vitro and in silico study. Botany Letters. 2019;166(4):444–56.
   Web of Science ®Google Scholar
• Bodiga VL, Bodiga S. Renin angiotensin system in cognitive function and dementia. Asian Journal of Neuroscience. 2013;2013:1–18.
   Google Scholar
• Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A. Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry. 2006;21(6):550–5.
   PubMed Web of Science ®Google Scholar
• Yasar S, Varma VR, Harris GC, Carlson MC. Associations of angiotensin converting enzyme-1 and angiotensin II blood levels and cognitive function. J Alzheimers Dis. 2018;63(2):655–64.
   PubMed Web of Science ®Google Scholar
• Actis-Goretta L, Ottaviani JI, Fraga CG. Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem. 2006;54(1):229–34.
   PubMed Web of Science ®Google Scholar
• Liu Z, Nakamura T, Munemasa S, Murata Y, Nakamura Y. Galloylated catechins as potent inhibitors of angiotensin converting enzyme. Food Science and Technology Research. 2016;22:847.
   Web of Science ®Google Scholar
• Ali MY, Seong SH, Jung HA, Choi JS. Angiotensin-I-Converting enzyme inhibitory activity of coumarins from Angelica decursiva. Molecules. 2019;24(21).
   Web of Science ®Google Scholar
• Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, Filip M. Oxidative stress in neurodegenerative diseases. Mol Neurobiol. 2015;53(6):4094–125.
   PubMed Web of Science ®Google Scholar
• Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell B. 2007;39(1):44–84.
   PubMed Web of Science ®Google Scholar
• Nandi A, Yan LJ, Jana CK, Das N. Role of catalase in oxidative stress- and Age-associated Degenerative diseases. Oxid Med Cell Longev. 2019;2019:9613090.
   PubMed Web of Science ®Google Scholar
• Ogunsuyi OB, Ademiluyi AO, Oboh G, Oyeleye SI, Dada AF. Green leafy vegetables from two Solanum spp. (Solanum nigrum L and Solanum macrocarpon L) ameliorate scopolamine-induced cognitive and neurochemical impairments in rats. Food Sci Nutr. 2018;6(4):860–70.
   PubMed Web of Science ®Google Scholar
• Venkatesan R, Subedi L, Yeo EJ, Kim SY. Lactucopicrin ameliorates oxidative stress mediated by scopolamine-induced neurotoxicity through activation of the NRF2 pathway. Neurochem Int. 2016;99:133–46.
   PubMed Web of Science ®Google Scholar
• Olasehinde TA, Olaniran AO, Okoh AI. Aqueous-ethanol extracts of some South African seaweeds inhibit beta-amyloid aggregation, cholinesterases, and beta-secretase activities in vitro. J Food Biochem. 2019;43(7):e12870.
   PubMed Web of Science ®Google Scholar
• Braidy N, Grant R, Adams S, Guillemin GJ. Neuroprotective effects of naturally occurring polyphenols on quinolinic acid-induced excitotoxicity in human neurons. FEBS J. 2010;277(2):368–82.
   PubMed Web of Science ®Google Scholar